Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01727193Phase 3Completed
A Phase 3 trial of leflunomide in myasthenia gravis (MG), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01727193.